» Articles » PMID: 12610053

Contributions of Fasting and Postprandial Plasma Glucose Increments to the Overall Diurnal Hyperglycemia of Type 2 Diabetic Patients: Variations with Increasing Levels of HbA(1c)

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2003 Mar 1
PMID 12610053
Citations 409
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The exact contributions of postprandial and fasting glucose increments to overall hyperglycemia remain controversial. The discrepancies between the data published previously might be caused by the interference of several factors. To test the effect of overall glycemic control itself, we analyzed the diurnal glycemic profiles of type 2 diabetic patients investigated at different levels of HbA(1c).

Research Design And Methods: In 290 non-insulin- and non-acarbose-using patients with type 2 diabetes, plasma glucose (PG) concentrations were determined at fasting (8:00 A.M.) and during postprandial and postabsorptive periods (at 11:00 A.M., 2:00 P.M., and 5:00 P.M.). The areas under the curve above fasting PG concentrations (AUC(1)) and >6.1 mmol/l (AUC(2)) were calculated for further evaluation of the relative contributions of postprandial (AUC(1)/AUC(2), %) and fasting [(AUC(2) - AUC(1))/AUC(2), %] PG increments to the overall diurnal hyperglycemia. The data were compared over quintiles of HbA(1c).

Results: The relative contribution of postprandial glucose decreased progressively from the lowest (69.7%) to the highest quintile of HbA(1c) (30.5%, P < 0.001), whereas the relative contribution of fasting glucose increased gradually with increasing levels of HbA(1c): 30.3% in the lowest vs. 69.5% in the highest quintile (P < 0.001).

Conclusions: The relative contribution of postprandial glucose excursions is predominant in fairly controlled patients, whereas the contribution of fasting hyperglycemia increases gradually with diabetes worsening. These results could therefore provide a unifying explanation for the discrepancies as observed in previous studies.

Citing Articles

A Randomized, Placebo-Controlled, Single-Center, Crossover Study to Evaluate the Effects of Pre-Meal Whey Protein Microgel on Post-Prandial Glucometabolic and Amino Acid Response in People with Type 2 Diabetes and Overweight or Obesity.

Neeland I, de Gregorio L, Zagury R, Ahren B, Neutel J, Darimont C Metabolites. 2025; 15(1).

PMID: 39852403 PMC: 11767963. DOI: 10.3390/metabo15010061.


Postprandial Plasma Glucose.

Aung N Clin Diabetes. 2025; 43(1):161-164.

PMID: 39829699 PMC: 11739343. DOI: 10.2337/cd24-0099.


The Impact of Physical Activity in Patients With Type 2 Diabetes.

Bassin S, Srinath R Am J Lifestyle Med. 2025; 19(1):147-161.

PMID: 39822318 PMC: 11733108. DOI: 10.1177/15598276231180541.


Effect of medium-chain triglycerides and whey protein isolate preloads on glycaemia in type 2 diabetes: a randomized crossover study.

Pabla P, Mallinson J, Nixon A, Keeton M, Cooper S, Marshall M Am J Clin Nutr. 2024; 121(2):232-245.

PMID: 39732398 PMC: 11863336. DOI: 10.1016/j.ajcnut.2024.12.022.


HM-Chromanone Alleviates Hyperglycemia by Activating AMPK and PI3K/AKT Pathways in Mice Fed a High-Fat Diet.

Park J, Yoo J, Han J Nutrients. 2024; 16(22).

PMID: 39599757 PMC: 11597832. DOI: 10.3390/nu16223972.